Find clinical trials in your area

Search by disease and location to discover available clinical trials matching your criteria.

Matched clinical trials

  • Study Comparing Chemotherapy Alone to Chemotherapy with Nivolumab or Nivolumab and BMS-986205 for Patients with Muscle-Invasive Bladder Cancer

    Not recruiting

    1 1 1 1
    Investigated diseases:
    Austria Belgium Finland France Germany Greece +5
  • Study of Durvalumab with Gemcitabine and Cisplatin for Patients with Advanced Biliary Tract Cancer

    Not recruiting

    1 1 1 1
    Investigated diseases:
    Bulgaria France Italy Poland
  • Study on Guselkumab for Patients with Moderate-to-Severe Plaque Psoriasis

    Not recruiting

    1 1
    Investigated diseases:
    Investigated drugs:
    Germany
  • Study on Tiotropium for Preventing Severe Asthma Attacks in Preschool Children with Uncontrolled Asthma

    Not recruiting

    1 1
    Investigated diseases:
    Germany
  • Study of BMS-986012, carboplatin, etoposide and nivolumab combination as first treatment for patients with extensive-stage small cell lung cancer

    Not recruiting

    1 1 1
    Belgium Greece Italy The Netherlands Poland Romania +1
  • Study on the Safety and Effects of Volrustomig and Axitinib for Patients with Advanced Kidney Cancer

    Not recruiting

    1 1 1
    Investigated diseases:
    Investigated drugs:
    France Spain
  • Study on Reducing Hormone Therapy Duration with Exemestane, Letrozole, and Anastrozole in Post-Menopausal Women with Low-Risk Hormone-Sensitive Breast Cancer

    Not recruiting

    1 1 1
    France
  • Study of Durvalumab, Tremelimumab, and Bevacizumab for Patients with Non-Resectable Liver Cancer

    Not recruiting

    1 1 1
    Germany Italy
  • Study on Adjustable Brodalumab Dosage for Patients with Moderate-to-Severe Plaque Psoriasis Weighing 120 kg or More

    Not recruiting

    1 1 1
    Investigated drugs:
    Belgium Czechia France Germany Greece Hungary +3
  • Study of Durvalumab with Radiation Therapy for Patients with Early Stage Non-Small Cell Lung Cancer and Osimertinib for Those with EGFR Mutation

    Not recruiting

    1 1 1
    Belgium France Germany Greece Italy The Netherlands +2